RUBELLA VIRUS - ANVISA Registration 80146502031

Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502031 and manufactured by ABBOTT IRELAND DIAGNOSTIC DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Oct 31, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.